NCT03747133View on ClinicalTrials.gov

SABR for Renal Tumors

NARecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Renal Tumor
Interventions
RADIATION

Stereotactic Ablative Radiotherapy

Stereotactic Ablative Radiotherapy to renal tumors with a dose of 27.5-40 Gy in 5 fractions.

Trial Locations (2)

L4M 6M2

NOT_YET_RECRUITING

Royal Victoria Regional Health Centre, Barrie

M5G 2M9

RECRUITING

University Health Network - Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER